98%
921
2 minutes
20
The SARS-CoV-2 polymerase NiRAN domain initiates RNA capping. Previous results showed that both GTP and GDP can be utilized by NiRAN to yield GpppA together with RNAylated nsp9 (RNA-nsp9); however, the G-pocket substrate selection and the working mechanism of NiRAN remain unclear. Small et al. questioned the binding of the non-hydrolyzable GTP analog GMPPNP in the G-pocket of the RTC:RNA-nsp9:GMPPNP structure (PDB: 8GWE) and proposed that the GTP-mediated RNA-capping mechanism remains unresolved. Here, we show the optimized density derived from the original data to support the modeling of GMPPNP, and we reveal why the alternative data processing method failed to obtain density results. We provide additional biochemical and structural evidence by using GTP, GDP, GMPPNP, and GDP⋅BeF as probes to clarify the GTP-mediated RNA-capping mechanism and reconcile the two currently known models by using GTP and GDP as substrates. This Matters Arising Response addresses the Small et al. (2025) Matters Arising paper, published concurrently in Cell.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cell.2025.05.045 | DOI Listing |
PLoS Genet
September 2025
Department of Biology/Chemistry, Division of Genetics, University of Osnabrück, Barbarastrasse, Osnabrück, Germany.
The small GTPase Rho5 has been shown to be involved in regulating the Baker's yeast response to stress on the cell wall, high medium osmolarity, and reactive oxygen species. These stress conditions trigger a rapid translocation of Rho5 and its dimeric GDP/GTP exchange factor (GEF) to the mitochondrial surface, which was also observed upon glucose starvation. We here show that rho5 deletions affect carbohydrate metabolism both at the transcriptomic and the proteomic level, in addition to cell wall and mitochondrial composition.
View Article and Find Full Text PDFbioRxiv
August 2025
Department of Structural Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
The RAS family of small GTPases are molecular switches that convey downstream signals regulating cell proliferation, differentiation, and apoptosis. The signaling competent GTP-bound RAS transitions to its inactive GDP-bound form through γ-phosphate hydrolysis. Oncogenic RAS mutations hamper GTP hydrolysis and are present in up to 30% of all human cancers.
View Article and Find Full Text PDFbioRxiv
August 2025
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE.
Altered lipid metabolism and lipid droplet (LD) dynamics are hallmark features of hepatocellular carcinoma (HCC) subtypes, but the molecular mechanisms governing LD trafficking and catabolism in HCC cells remain unclear. The small GTPase Rab5, a key regulator of early endosomal dynamics, has been observed to localize to the surface of LDs, suggesting it may play a role in LD turnover. However, the regulation of Rab5-LD interactions and its functional consequences in HCC cell metabolism and proliferation have not been elucidated.
View Article and Find Full Text PDFBiophys J
August 2025
Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180; Department of Biological Sciences, Rensselaer Polytechnic Institute, Troy, NY 12180; Graduate Program in Biochemistry and Biophysics, Rensselaer Polytechnic Institute, Troy, NY 12180.
The Arf and Arf-like GTPases, unlike all other Ras family GTPase members, exhibit a repressed conformation in their inactive, GDP-bound form. An important component of this autoinhibition is their N-terminal helix, which is missing in the other Ras family members. This helix caps a switch element called the interswitch, confining it to this repressed state.
View Article and Find Full Text PDFSci Rep
August 2025
Faculty of Chemistry, University of Warsaw, 02-093, Warsaw, Poland.
Orexins are hypothalamic neuropeptides primarily involved in regulating the sleep/wakefulness cycle and circadian rhythm. They bind to the orexin receptor type 1 (OX) and type 2 (OX), well-known drug targets in the treatment of sleep disorders, that have recently been shown to play a significant role in different cancers. Lemborexant is one of a few orexin receptor antagonists that have been approved for the treatment of insomnia.
View Article and Find Full Text PDF